三种替代尼古丁输送产品对燃烧香烟使用的影响:随机对照试验
Megan E Piper1,2, Tanya R Schlam1,3, Eric C Donny4
1Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
非常低尼古丁含量香烟 (VLNC) 和电子香烟同样减少了成年吸烟者的每日香烟消耗. 尼古丁贴片的使用没有显著改变这种减少,突出显示了行为替代在戒烟中的作用.
科学领域:
- 公共卫生 公共卫生
- 行为科学 行为科学
- 尼古丁成研究 尼古丁成研究
背景情况:
- 戒烟是一个关键的公共卫生目标.
- 研究有效的香烟替代品对于减少吸烟率至关重要.
- 了解与尼古丁依赖相关的行为因素对于戒烟成功至关重要.
研究的目的:
- 评估电子烟和极低尼古丁含量香烟 (VLNC) 作为传统香烟的替代品.
- 为了确定尼古丁替代疗法 (尼古丁贴片) 是否增强了替代效应.
- 评估这些替代品对成年人每日吸烟消费的影响,这些成年人没有戒烟的动力.
主要方法:
- 一个混合设计实验,涉及160名成年每日吸烟者,他们没有动机戒烟.
- 将VLNC,电子烟或没有研究产品随机分配到4周.
- 包括两周使用活性和安慰剂尼古丁贴片 (双盲,平衡) 进行切换,以评估贴片效应.
主要成果:
- 与无产品组相比,VLNC和电子烟都显著减少了每日吸烟.
- 在VLNC和电子烟组之间,没有观察到香烟减少的显著差异.
- 尼古丁贴片并没有显著影响吸烟的普通品牌香烟的数量,这表明替代效应与贴片无关.
结论:
- 电子烟和VLNC是减少日常烟草消费的有效行为替代品.
- 从替代产品或贴片中输送的尼古丁并没有显著改变吸烟的减少.
- 行为替代,独立于尼古丁,在减少吸烟行为方面发挥着重要作用,这表明需要在戒烟干预中解决行为因素.
更多相关视频
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
相关概念视频
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
Drug Dependence
Statistical Methods for Analyzing Epidemiological Data
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
